Stockreport

Roche says breast cancer late-stage study met primary endpoint [Reuters]

ROCHE HOLDING LTD S/ADR  (RHHBY) 
NASDAQ:AMEX Investor Relations: roche.com/investors.htm
PDF Roche says breast cancer late-stage study met primary endpoint | Reuters 1 Min Read ZURICH, Oct 15 (Reuters) - Roche said its Kadcyla, an antibody drug to treat breast c [Read more]